Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep822 | Steroid metabolism + action | ECE2017

Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole

Beck Katharina , Kratschmar Denise , Meyer Arne , Schuster Daniela , Odermatt Alex

Impaired 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2)-dependent cortisol inactivation can lead to electrolyte dysbalance, hypertension and cardiometabolic disease. Furthermore, placental 11β-HSD2 essentially protects the fetus from high maternal glucocorticoid levels, and its impaired function has been associated with altered fetal growth and a higher risk for cardio-metabolic diseases in later life. Despite its important role, 11β-HSD2 is not include...

ea0081ep874 | Reproductive and Developmental Endocrinology | ECE2022

Have we ignored red cell parameters in Turner Syndrome? Results from a single specialist centre

Beck Katharina , Dilrukshi M d s a , Calanchini Matilde , Roy Noemi B A , Turner Helen E

Introduction: Anaemia and other haematological disorders have been reported in Turner Syndrome (TS). TS-related comorbidities (premature ovarian insufficiency, autoimmune hypothyroidism, coeliac disease and liver diseases) and treatments (hormone replacement [HRT] and growth hormone) are possible explanations. We aim to investigate the prevalence of abnormal full blood count (FBC) in adult TS and assess associated clinical characteristics.Methods: FBC pa...

ea0094p110 | Reproductive Endocrinology | SFEBES2023

Do all women with turner syndrome with 45, X/46, XY mosaic karyotype need early gonadectomy?: Experience from an adult tertiary care centre

A D Mathara Diddhenipothage Mathara Diddhenipothage Shani , J Beck Beck Katharina , Calanchini Matilde , Shears Deborah , E Turner Helen

Introduction: Reports suggest the karyotype of up to 10% of women with Turner syndrome (TS) includes presence of a Y chromosome. Current guidelines recommend early gonadectomy given the potential risk of gonadoblastoma. However, the evidence basis for this practice is not strong. We aimed to assess pubertal development, clinical features, incidence of gonadoblastoma and long-term outcome including pregnancy in an adult-tertiary care TS clinic.<p class="abs...

ea0050p005 | Adrenal and Steroids | SFEBES2017

20β-Dihydrocortisol; a weak endogenous agonist of the glucocorticoid receptor but a potent agonist of the mineralocorticoid receptor

Morgan Ruth , Beck Katharina , Nixon Mark , Homer Natalie , Melchers Diana , Houtman Rene , Meijer Onno , Hadoke Patrick , Odermatt Alex , Keen John , Walker Brian

Cortisol conversion to 20β-dihydrocortisol (20β-DHF) has been reported in many tissues and cells, including skin, muscle, thrombocytes and fibroblasts, although the enzyme responsible is poorly characterised. We have attributed 20β-DHF generation to carbonyl reductase 1 and shown increased activity of this pathway in adipose tissue in obesity in humans, horses and mice. This study addressed the hypothesis that 20β-DHF activates gl...

ea0050p005 | Adrenal and Steroids | SFEBES2017

20β-Dihydrocortisol; a weak endogenous agonist of the glucocorticoid receptor but a potent agonist of the mineralocorticoid receptor

Morgan Ruth , Beck Katharina , Nixon Mark , Homer Natalie , Melchers Diana , Houtman Rene , Meijer Onno , Hadoke Patrick , Odermatt Alex , Keen John , Walker Brian

Cortisol conversion to 20β-dihydrocortisol (20β-DHF) has been reported in many tissues and cells, including skin, muscle, thrombocytes and fibroblasts, although the enzyme responsible is poorly characterised. We have attributed 20β-DHF generation to carbonyl reductase 1 and shown increased activity of this pathway in adipose tissue in obesity in humans, horses and mice. This study addressed the hypothesis that 20β-DHF activates gl...

ea0090ep1154 | Late Breaking | ECE2023

Prevalence, patterns, and characteristics of hypertension diagnosis and management in patients with Turner syndrome; Descriptive analysis of real-world data from the International-Turner Syndrome registry

Apsara Dilrukshi Mathara Diddhenipothage Shani , Beck Katharina , G K Amiyangoda C , Bryce Jillian , Cima Luminita , De Groote Katya , Deyanova Yana , Globa Eugenia , Herrmann Gloria , Juul Anders , Sophie. L Kjaer Anna , Tonnes Pedersen Pedersen Anette , Poyrazoglu Sukran , Probst-Scheidegger Ursina , C.J Sas Theo , Nimali Seneviratne Sumudu , Witczak Justyna , Orchard Elizabeth , Tomlinson Jeremy , Ahmed Faisal , Turner Helen

Introduction: Hypertension is common in patients with Turner Syndrome (TS), and they appear to have an increased predisposition with various proposed disease related factors; sex hormone imbalance, aortopathy, increased activation of the renin-angiotensin-aldosterone system, insulin resistance, growth hormone deficiency/resistance, adverse imprinting during fetal life and renal malformations. Despite high susceptibility and unique challenges in managing hypertension in this gr...

ea0094op3.1 | Reproductive Endocrinology | SFEBES2023

Are we giving enough attention to blood pressure control in turner syndrome? : Data from the international turner syndrome (I-TS) registry

Mathara Diddhenipothage Shani A.D. , Beck Katharina J. , Amiyangoda C G K , Bryce Jillian , Cima Luminita , De Groote Katya , Deyanova Yana , Globa Evgenia , Herrmann Gloria , Juul Anders , Sophie L. Kjaer Kjaer Anna , Tonnes Pedersen Anette , Poyrazoglu Sukran , Probst-Scheidegger Ursina , Sas Theo C.J. , Fica Simona , Nimali Seneviratne Sumudu , Karolina Witczak Justyna , Orchard Elizabeth , Tomlinson Jeremy W. , Faisal Ahmed S. , Turner Helen E

Introduction: Cardiovascular disease is the commonest cause of death (absolute-excess-risk:41%) in Turner Syndrome (TS). Hypertension is a major risk for circulatory-disease (up to 60%) and a key modifiable-risk factor of aortopathy, ischemic heart disease and stroke in TS. There is no current consensus for hypertension diagnosis/management in TS.Methods: Retrospective multi-centre observational study of patients aged &#...